NCT06001034 is a NA clinical trial of Occlusion training in Fibromyalgia, sponsored by José Carlos Rodríguez Bautista.

Who is sponsoring NCT06001034?

NCT06001034 is sponsored by José Carlos Rodríguez Bautista.

What drugs are being tested in NCT06001034?

Interventions in NCT06001034: Occlusion training.

What condition does NCT06001034 study?

NCT06001034 studies Fibromyalgia.

Is NCT06001034 still recruiting?

NCT06001034 is currently completed. Last updated 21 August 2023.

Last reviewed 2023-08-21 · How we verify

NCT06001034

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Program of Supervised Occlusive Aerobic Training in People With Fibromyalgia.

Completed NA Last updated 21 August 2023

What this trial tests

NA trial testing Occlusion training in Fibromyalgia in 37 participants. Completed in 20 May 2023.

Timeline

15 September 2022

Primary endpoint
5 February 2023

20 May 2023

Quick facts

Lead sponsor	José Carlos Rodríguez Bautista
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	37
Start date	15 September 2022
Primary completion	5 February 2023
Estimated completion	20 May 2023
Sites	1 location across Spain

Drugs / interventions tested

Occlusion training

Conditions studied

Fibromyalgia — all drugs for Fibromyalgia →

Sponsor

José Carlos Rodríguez Bautista

Who can join

Adults 18 to 70, female only, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Occlusive training in people with fibromyalgia

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility, Safety, and Effects of an Aerobic Training Program with Blood Flow Restriction on Functional Capacity, and Symptomatology in Women with Fibromyalgia: A Pilot Study.
Rodríguez-Bautista JC, López-Lluch G, Rodríguez-Torres P, López-Moral Á, et al · · 2024 · cited 3× · PMID 39200359 · DOI 10.3390/biomedicines12081895

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06001034 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by José Carlos Rodríguez Bautista
Last refreshed: 21 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06001034.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing